577 / 1674
TARGIT-R: North America experience
Valente SA et al, Ann Surg Oncol 2016
First patient in 2007, 935 at July 2013
19/30 center with Intrabeam
90% suitable for ASTRO
Pre-pathology 79%
IORT alone in 83%
IBTR at 23.3 months: 2.3%
Nodal Recurrence: 0.2%
Contralateral breast: 0.9%
Metastatic disease: 0.3%